STEVENS CAPITAL MANAGEMENT LP - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$79,000
-70.8%
10,292
-59.0%
0.00%
-72.7%
Q4 2015$271,000
+23.2%
25,080
+0.8%
0.01%
+37.5%
Q2 2015$220,000
+8.4%
24,873
+22.5%
0.01%
+33.3%
Q3 2014$203,000
+28.5%
20,308
-2.6%
0.01%
+50.0%
Q2 2014$158,00020,8560.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders